EYMIRAS
Live / Registered — Registered (as of 05 Apr 2022)
What this means for you
Registered since 05 Apr 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97008028
- Registration number
- 6694189
- Mark type
- Stylized text
- Filed
- 02 Sept 2021
- Published for opposition
- 30 Nov 2021
- Registered
- 05 Apr 2022
- Attorney of record
- Michele M. Glessner
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of cataracts, glaucoma, ocular hypertension, pinguecula, chalazion, uveitis, and eye diseases and conditions; pharmaceutical preparations, namely, collyrium, eye drops, ophthalmic preparations, and ophthalmic ointments for the treatment of eye diseases and conditions; pharmaceutical preparations for use in eye injections for the treatment of eye diseases and conditions
Owner
- Santen Pharmaceutical Co., Ltd., Osaka, JP
- Santen Pharmaceutical Co., Ltd., Osaka, JP
- Santen Pharmaceutical Co., Ltd., Osaka, JP
Prosecution history
- 05 Apr 2022 — REGISTERED-PRINCIPAL REGISTER
- 02 Mar 2022 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 28 Jan 2022 — NOTICE OF ALLOWANCE CANCELLED
- 02 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 28 Jan 2022 — TEAS DELETE 1(B) BASIS RECEIVED
- 25 Jan 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 30 Nov 2021 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 30 Nov 2021 — PUBLISHED FOR OPPOSITION
- 10 Nov 2021 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Oct 2021 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Oct 2021 — ASSIGNED TO EXAMINER
- 16 Oct 2021 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 06 Sept 2021 — NEW APPLICATION ENTERED